Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
1.910
+0.020 (1.06%)
At close: Mar 28, 2025, 4:00 PM
1.904
-0.006 (-0.29%)
After-hours: Mar 28, 2025, 6:00 PM EDT

Vigil Neuroscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
27.3827.9321.4410.083.55
Research & Development
62.3160.9347.4432.339.03
Operating Expenses
89.6888.8768.8842.4112.58
Operating Income
-89.68-88.87-68.88-42.41-12.58
Interest & Investment Income
5.426.240.620-
Currency Exchange Gain (Loss)
-0.01-0.02---
Other Non Operating Income (Expenses)
---0.04-0.88-2.66
EBT Excluding Unusual Items
-84.27-82.65-68.31-43.28-15.25
Gain (Loss) on Sale of Investments
0.020.01---
Pretax Income
-84.26-82.64-68.31-43.28-57.09
Net Income
-84.26-82.64-68.31-43.28-57.09
Net Income to Common
-84.26-82.64-68.31-43.28-57.09
Shares Outstanding (Basic)
41393221
Shares Outstanding (Diluted)
41393221
Shares Change (YoY)
5.05%22.18%1968.64%13.48%-
EPS (Basic)
-2.07-2.13-2.16-28.26-42.30
EPS (Diluted)
-2.07-2.13-2.16-28.26-42.30
Free Cash Flow
-51.23-71.04-66.07-39.55-10.36
Free Cash Flow Per Share
-1.26-1.83-2.08-25.82-7.68
EBITDA
-89.23-88.47-68.81-42.38-
D&A For EBITDA
0.450.40.080.03-
EBIT
-89.68-88.87-68.88-42.41-12.58
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q